Effectiveness and cost-effectiveness of a personalised self-management support intervention for non-hospitalised people living with long COVID

Not Applicable

Completed

• Conditions: ong COVID-19; Infections and Infestations

• Registration Number: ISRCTN36407216
• Lead Sponsor: Kingston University

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36726167/ (added 03/02/2023) 2024 Other publications in https://doi.org/10.1186/s12889-024-18267-6 An exploration of the experiences and self-generated strategies used when navigating everyday life with Long Covid (added 14/03/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-27
• Study Completion: 2023-07-31
• Last Update Posted: 29 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 554

Inclusion Criteria

1. Age =18 years, AND
2. English or Welsh speaker or have access to someone who can act as a translator
3. Consulted with their GP to rule out serious complications or the need for further investigation in relation to persistent symptoms following COVID-19 infection, AND
4. Experience persistent illness (at least one long COVID symptom for 12 weeks or longer, AND
4.1 Positive SARS-CoV-2 PCR or antigen test (positive COVID19 test) during the acute phase of illness, OR
4.2 Positive SARS-CoV-2 antibody test (positive COVID-19 antibody test) at any time point in the absence of SARS-CoV-2 ( COVID-19) vaccination history, OR
4.3 Loss of sense of smell or taste during the acute phase in the absence of any other identified cause, OR
4.4 Symptoms consistent with SARS-CoV-2 ( COVID-19) infection during the acute phase and high prevalence of COVID-19 at time and location of onset, OR
4.5 At least one symptom consistent with SARS-CoV-2 ( COVID-19) infection during the acute phase AND close contact of a confirmed case of COVID-19 around the time of onset

Exclusion Criteria

1. Any co-morbidities which are progressive or requiring palliative treatment.
2. Have been hospitalised for treatment of COVID-19 symptoms, during the acute phase of COVID illness.
3. Are currently participating in any COVID intervention trial (including contributing to the LISTEN co-design activities).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The impact of the LISTEN intervention on routine activities is assessed using the routine activities scale domain of the Oxford Participation and Activities Questionnaire (Ox-PAQ) at baseline and 3 months.